2024 ASCO® Annual Meeting Insights Hub

Meeting coverage & Vumedi’s exclusive highlights, all in one place.

 

ASCO® 2024 Insights: "CheckMate 67T Trial - Safety & PROs of Subcutaneous vs. IV Nivo in Previously Treated Advanced or Metastatic ccRCC"

97 views
June 7, 2024

Chapters

CheckMate 67T Study Overview & Endpoints

00:00

Safety, Immunogenicity & Patient Experiences

01:12

Comments 0
Login to view comments. Click here to Login